Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection

Life Sciences

Volumn 135, Issue , 2015, Pages 68-76

  Testai, Lara ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cardioprotection; Flavonoids; Mitochondrial pharmacology; Mitochondrial target

Indexed keywords

ANTHOCYANIDIN; ANTHOCYANIN; FLAVAN 3 OL; FLAVAN DERIVATIVE; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; ISOFLAVONE; LUTEOLIN; NARINGENIN; POTASSIUM CHANNEL; PROTEIN KINASE; PUERARIN; QUERCETIN; UNCLASSIFIED DRUG; VASODILATOR AGENT; CARDIOTONIC AGENT;

ANTIOXIDANT ACTIVITY; APPLE; BLUEBERRY; BROCCOLI; CITRUS FRUIT; DRUG ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRION; MITOCHONDRIOTROPIC ACTIVITY; NONHUMAN; ONION; OXIDATIVE PHOSPHORYLATION; PHARMACOLOGY; RED WINE; RESPIRATORY CHAIN; REVIEW; TEA; VASODILATATION; ACUTE DISEASE; HEART MITOCHONDRION; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY;

ANIMALIA;

ACUTE DISEASE; CARDIOTONIC AGENTS; FLAVONOIDS; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA;

EID: 84934935922     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.04.017     Document Type: Review

References (140)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P.M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M.M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V.L. Roger, W. Rosamond, R. Sacco, P. Sorlie, V.L. Roger, T. Thom, S. Wasserthiel-Smoller, N.D. Wong, and J. Wylie-Rosett American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 215
2. N. Vanlangenakker, B.T. Vanden, and P. Vandenabeele Many stimuli pull the necrotic trigger, an overview Cell Death Differ. 19 2012 75 86
3. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N. Engl. J. Med. 357 2007 1121 1135
4. L.G. Kevin, A.K.S. Camara, M.L. Riess, E. Novalija, and D.F. Stowe Ischemic preconditioning alters real-time measure of O2-radicals in intact hearts with ischemia and reperfusion Am. J. Phys. 284 2003 H566 H574
5. A.P. Halestrap, S.J. Clarke, and S. Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioproteciton Cardiovasc. Res. 61 2004 372 385
6. A.P. Halestrap, P.M. Kerr, S. Javadov, and K.Y. Woodfield Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart Biochim. Biophys. Acta 1366 1998 79 94
7. P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Pharmacol. Rev. 58 2006 87 114
8. G. Solaini, and D.A. Harris Biochemical dysfunction in heart mitochondria exposed to ischemia and reperfusion Biochem. J. 390 2005 377 394
9. A.P. Halestrap Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7 - implications for the protective effect of low pH against chemical and hypoxic cell damage Biochem. J. 278 1991 715 719
10. D.R. Hunter, R.A. Haworth, and J.H. Southard Relationship between configuration, function, and permeability in calcium-treated mitochondria J. Biol. Chem. 251 1976 5069 5077
11. J.S. Kim, Y.G. Jin, and J.J. Lemasters Reactive oxygen species, but not Ca2 + overloading trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion Am. J. Phys. 290 2006 H2024 H2034
12. Y. Kimura, R. Iyengar, R. Subramanian, G.A. Cordis, and D.K. Das Preconditioning of the heart by repeated stunning: attenuation of post-ischemic dysfunction Basic Res. Cardiol. 87 1992 128 138
13. P. Bernardi Mitochondrial transport of cations: channels, exchangers and permeability transition Physiol. Rev. 79 1999 1127 1155
14. E. Doran, and A.P. Halestrap Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites Biochem. J. 348 2000 343 350
15. J.C. Martinou, and D.R. Green Breaking the mitochondrial barrier Nat. Rev. Mol. Cell Biol. 2 2001 63 67
16. E.J. Griffiths, and A.P. Halestrap Protection by cyclosporine A of ischemia-reperfusion-induced damage in isolated rat hearts J. Mol. Cell. Cardiol. 25 1993 1461 1469
17. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
18. S.A. Javadov, S. Clarke, M. Das, E.J. Griffiths, K.H.H. Lim, and A.P. Halestrap Ischemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart J. Physiol. 549 2003 513 524
19. R.A. Kloner, and S.H. Rezkalla Preconditioning, postconditioning and their application to clinical cardiology Cardiovasc. Res. 70 2006 297 307
20. D.M. Yellon, and J.M. Downey Preconditioning the myocardium: from cellular physiology to clinical cardiology Physiol. Rev. 83 2003 1113 1151
21. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, R.A. Guyton, and J. Vinten-Johansen Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am. J. Physiol. Heart Circ. Physiol. 285 2003 H579 H588
22. S. Trumbeckaite, J. Bernatoniene, D. Majiene, V. Jakstas, A. Savickas, and A. Toleikis The effect of flavonoids on rat heart mitochondrial function Biomed. Pharmacother. 60 2006 245 248
23. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, I. L'huillir, J.F. Aupetit, E. Bonnefoy, G. Finet, X. André-Fouët, and M. Ovize Postconditioning the human heart Circulation 112 2005 2143 2148
24. G. Liu, J. Thornton, D. Van Winkle, A. Stanley, R. Olsson, and J. Downey Protection again infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart Circulation 84 1991 350 356
25. Z. Yao, and G.J. Gross Acetylcholine mimics ischemic preconditioning via a glybenclamide-sensitive mechanism in dogs Am. J. Physiol. Heart Circ. Physiol. 264 1993 H2221 H2225
26. R. Schulz, H. Post, C. Vahlhaus, and G. Heusch Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin Circulation 98 1998 1022 1029
27. R.M. Fryer, J.E. Schultz, A.K. Hsu, and G.J. Gross Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts Am. J. Phys. 276 1999 H1229 H1235
28. R. Schulz, J. Rose, H. Post, and G. Heusch Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels Am. J. Phys. 268 1995 H2294 H2301
29. E.R. Schwarz, W.S. Whyte, and R.A. Kloner Ischemic preconditioning Curr. Opin. Cardiol. 12 1997 475 481
30. G.Y. Wang, S. Wu, J.M. Pei, X.C. Yu, and T.M. Wong Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats Am. J. Physiol. Heart Circ. Physiol. 280 2001 H384 H391
31. J. Weil, T. Eschenhagen, G. Fleige, C. Mittmann, E. Orthey, and H. Scholz Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium Am. J. Phys. 275 1998 H378 H384
32. W.M. Zhang, W.Q. Jin, and T.M. Wong Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma J. Mol. Cell. Cardiol. 28 1996 1547 1554
33. R. Bolli Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research J. Mol. Cell. Cardiol. 33 2001 1897 1918
34. S.P. Jones, and R. Bolli The ubiquitous role of nitric oxide in cardioprotection J. Mol. Cell. Cardiol. 40 2006 16 23
35. A. Lochner, E. Marais, S. Genade, and J.A. Moolman Nitric oxide: a trigger for classic preconditioning? Am. J. Physiol. Heart Circ. Physiol. 279 2000 H2752 H2765
36. Z. Zhang, H. Huang, P. Liu, C. Tang, and J. Wang Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening KATP channels Can. J. Physiol. Pharmacol. 85 2007 1248 1253
37. C.P. Baines, J. Zhang, G.W. Wang, Y.T. Zheng, J.X. Xiu, E.M. Cardwell, R. Bolli, and P. Ping Mitochondrial PKC epsilon and MAPK form signaling modules in the murine heart. Enhanced mitochondrial PKC-epsilon MAPK interactions and differential MAPK activation in PKC epsilon-induced cardioprotection Circ. Res. 90 2002 390 397
38. P. Ping, J. Zhang, Y. Qui, X.L. Tang, S. Manchikalapuldi, X. Cao, and R. Bolli Ischemic preconditioning induces selective translocation of protein kinase C isoforms and in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity Circ. Res. 81 1997 404 414
39. C.P. Baines, C.X. Song, Y.T. Zheng, G.W. Wang, J. Zhang, O.L. Wang, Y. Guo, R. Bolli, E.M. Cardwell, and P. Ping Protein kinase C epsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria Circ. Res. 92 2003 873 880
40. R. Madonna, R. Bolli, G. Rokosh, and R. De Caterina Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection J Cardiovasc Med. 14 2013 249 253
41. M.M. Jeyaraman, W. Srisakuldee, B.E. Nickel, and E. Kardami Connexin43 phosphorylation and cytoprotection in the heart Biochim. Biophys. Acta 2012 1818 2009 2013
42. B.Z. Simkhovich, K. Przyklenk, and R.A. Kloner Role of protein kinase C in ischemic "conditioning": from first evidence to current perspectives J. Cardiovasc. Pharmacol. Ther. 18 2013 525 532
43. I. Inoue, H. Nagase, K. Kishi, and T. Higuti ATP-sensitive K + channel in the mitochondrial inner membrane Nature 352 1991 244 247
44. U. De Marchi, N. Sassi, B. Fioretti, L. Catacuzzeno, G.M. Cereghetti, I. Szabò, and M. Zoratti Intermediate conductance Ca2 +-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells Cell Calcium 45 2009 509 516
45. D. Siemen, C. Loupatatzis, J. Borecky, E. Gulbins, and F. Lang Ca2 +-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line Biochem. Biophys. Res. Commun. 257 1999 549 554
46. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study Lancet 342 1993 1007 1011
47. A. Basu, M. Rhone, and T.J. Lyons Berries: emerging impact on cardiovascular health Nutr. Rev. 68 2010 168 177
48. A. Cassidy, K.J. Mukamal, L. Liu, M. Franz, A.H. Eliassen, and E.B. Rimm High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women Circulation 127 2013 188 196
49. J.W. Erdman, D. Balentine, L. Arab, G. Beecher, J.T. Dwyer, J. Folts, J. Harnly, P. Hollman, C.L. Keen, G. Mazza, M. Messina, A. Scalbert, J. Vita, G. Williamson, and J. Burrowes Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop J. Nutr. 137 2007 S718 S737
50. P. Knekt, R. Jarvinen, A. Reunanen, and J. Maatela Flavonoid intake and coronary mortality in Finland: a cohort study BMJ 312 1996 478 481
51. P.J. Mink, C.G. Scrafford, L.M. Barraj, L. Harnack, C.P. Hong, J.A. Nettleton, and D.R. Jacobs Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women Am. J. Clin. Nutr. 85 2007 895 909
52. J. Mursu, S. Voutilainen, T. Nurmi, T.P. Tuomainen, S. Kurl, and J.T. Salonen Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study Br. J. Nutr. 4 2008 890 895
53. R.J. Robbins, C. Kwik-Uribe, J.F. Hammerstone, and H.H. Schmitz Analysis of flavonols in foods: what methods are required to enable meaningful health recommendations? J. Cardiovasc. Pharmacol. 47 2006 S110 S118
54. I. Rudkowska Functional foods for cardiovascular disease in women Menopause Int. 14 2008 63 69
55. I. Rudkowska, and P.J. Jones Functional foods for prevention and treatment of cardiovascular diseases: cholesterol and beyond Expert. Rev. Cardiovasc. Ther. 5 2007 477 490
56. L. Scheid, A. Reusch, P. Stehle, and S. Ellinger Antioxidant effects of cocoa and cocoa products ex vivo and in vivo: is there evidence from controlled intervention studies? Curr. Opin. Clin. Nutr. Metab. Care 13 2010 737 742
57. H. Schroeter, C. Heiss, J.P. Spencer, C.L. Keen, J.R. Lupton, and H.H. Schmitz Recommending flavonols and procyanidins for cardiovascular health: current knowledge and future needs Mol. Asp. Med. 31 2010 546 557
58. H. Sies Polyphenols and health: update and perspectives Arch. Biochem. Biophys. 501 2010 2 5
59. F.M. Steinberg, M.M. Bearden, and C.L. Keen Cocoa and chocolate flavonoids: implications for cardiovascular health J. Am. Diet. Assoc. 103 2003 215 233
60. P.F. Higher Jacques, A. Cassidy, G. Rogers, J.J. Peterson, J.B. Meigs, and J.T. Dwyer Dietary flavonol intake is associated with lower incidence of type 2 diabetes J. Nutr. 143 2013 1474 1480
61. W. Jiang, H. Wei, and B. He Dietary flavonoids intake and the risk of coronary heart disease: a dose-response meta-analysis of 15 prospective studies Thromb. Res. 2014 10.1016/j
62. I.C. Arts, and P. Hollman Polyphenols and disease risk in epidemiological studies Am. J. Clin. Nutr. 81 2005 S317 S325
63. M.G. Hertog, P.C. Hollman, and B. van de Putte Content of potentially anticarcinogenic flavonids of tea infusion wines, and fruit juices J. Agric. Food Chem. 41 1993 1242 1246
64. J.J. Peterson, J.T. Dwyer, P.F. Jacques, and M.L. McCullogh Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations Nutr. Rev. 70 2012 491 508
65. U. Peters, C. Poole, and L. Arab Does tea affect cardiovascular disease? A meta-analysis Am. J. Epidemiol. 154 2001 495 503
66. A. Di Castelnuovo, S. Rotondo, L. Iacoviello, M.B. Donati, and G. De Gaetano Meta-analysis of wine and beer consumption in relation to vascular risk Circulation 105 2002 2836 2844
67. H.S. Demrow, P.R. Slane, and J.D. Folts Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries Circulation 91 1995 1182 1188
68. M.G. Hertog, P.C. Hollman, and M.B. Katan Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands J. Agric. Food Chem. 40 1992 2379 2383
69. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability M J Lin Nutr. 79 2004 727 747
70. P.A. Murphy, T. Song, G. Buseman, K. Barua, G.R. Beecher, D. Trainer, and J. Holden Isoflavones in retail and institutional soy foods J. Agric. Food Chem. 47 1999 2697 2704
71. G. Mazza Anthocyanins in grapes and grape products Crit. Rev. Food Sci. Nutr. 35 1995 341 371
72. B. Frei, and J.V. Higdon Antioxidant activity of tea polyphenols in vivo: evidence from animal studies J. Nutr. 133 2003 3275S 3284S
73. M. Zhang, and L. Chen Status of cytokines in ischemia reperfusion induced heart injury Cardiovasc. Hematol. Disord. Drug Targets 8 2008 161 172
74. S.Y. Zhang, G. Chen, P.F. Wei, X.S. Huang, Y. Dai, Y.J. Shen, S.L. Chen, C.A. Sun-Chi, and H.X. Xu The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction J. Asian Nat. Prod. Res. 10 2008 373 381
75. Y.C. Chen, S.C. Shen, W.R. Lee, W.C. Hou, L.L. Yang, and T.J. Lee Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW264.7 macrophages J. Cell. Biochem. 82 2001 537 548
76. S.K. Ha, P. Lee, J.A. Park, H.R. Oh, S.Y. Lee, J.H. Park, E.H. Lee, J.H. Ryu, K.R. Lee, and S.Y. Kim Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model Neurochem. Int. 52 2008 878 886
77. H.K. Kim, B.S. Choen, Y.H. Kim, and H.P. Kim Effects of naturally occurring flavonoids on nitric oxide production in the macrophages cell line RAW 264.7 and their structure-activity relationships Biochem. Pharmacol. 58 1999 759 765
78. Y.C. Liang, Y.T. Huang, S.H. Tsai, S.Y. Lin-Shiau, C.F. Chen, and J.K. Lin Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and relates flavonoids in mouse macrophages Carcinogenesis 29 1999 1945 1952
79. G.M. Raso, R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophages J774 Life Sci. 496 2001 12 18
80. S.A. Van Acker, M.J. de Groot, D.J. van den Berg, M.N. Trompm, G. Donne-Op den Kelder, W.J. van der Vijgh, and A. Bast A quantum chemical exploration of the antioxidant activity of flavonoids Chem. Res. Toxicol. 9 1996 1305 1312
81. H.J. Kim, I. Tsoy, J.M. Park, J.I. Chung, S.C. Shin, and K.C. Chang Anthocyanins from soybean seed coat inhibit the expression of TNF-α-induced genes associated with ischemia/reperfusion in endothelial cell by NF-kappaB-dependent pathway and reduce rat myocardial damages incurred by ischemia and reperfusion in vivo FEBS Lett. 580 2006 1391 1397
82. W.Y. Huang, J. Wang, Y.M. Liu, Q.S. Zheng, and C.Y. Li Inhibitory effect of malvidin on TNF-α-induced inflammatory response in endothelial cells Eur. J. Pharmacol. 723 2014 67 72
83. L. Dong, Y. Fan, X. Shao, and Z. Chen Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis Food Chem. Toxicol. 49 2011 3211 3216
84. X. Dong, T. Liu, J. Yan, P. Wu, J. Chen, and Y. Hu Synthesis, biological evaluation and quantitative structure-activity relationship of flavonoids as vasorelaxant agents Bioorg. Med. Chem. 17 2009 716 726
85. J. Duarte, V. Perez, P. Utrilla, J. Jimenez, J. Tamargo, and A. Zarzuelo Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships Gen. Pharmacol. 24 1993 857 862
86. S.B. Jeon, G. Kim, J.I. Kim, Y.M. Seok, S.H. Kim, K. Suk, H.M. Shin, Y.H. Lee, and I.K. Kim Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphate target subunit Clin. Exp. Pharmacol. Physiol. 34 2007 1116 1120
87. Y.C. Xu, S.W. Leung, D.K. Yeung, L.H. Hu, G.H. Chen, C.M. Che, and R.Y. Man Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery Phytochem. 68 2007 1179 1188
88. E.C. Chan, P. Pannangpetch, and O.I. Woodman Relaxation to flavons and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships J. Cardiovasc. Pharmacol. 35 2000 326 333
89. F.N. Ko, T.F. Huang, and C.M. Teng Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta Biochim. Biophys. Acta 1115 1991 69 74
90. S.K. Mishram, S.E. Abbot, Z. Choudhury, M. Cheng, N. Khatab, N.J. Maycock, A. Zavery, and P.J. Aaronson Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein Cardiovasc. Res. 46 2000 539 546
91. M.A. Potenza, F.L. Marasciulo, M. Tarquinio, E. Tiravanti, G. Colantuono, A. Federici, J.A. Kim, M.J. Quon, and M. Montagnani EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR Am. J. Physiol. Endocrinol. Metab. 292 2007 E1378 E1387
92. S. Tan, S. Zhou, and Y. Luo Baicalein pretreatment confers cardioprotection against acute myocardial infarction by activating the endothelial nitric oxide synthase signaling pathway and inhibiting oxidative stress Mol Med Rep. 9 2014 2429 2434
93. C.X. Qin, X. Chen, R.A. Hughes, S.J. Williams, and O.L. Woodman Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity J. Med. Chem. 27 2008 1874 1884
94. V. Calderone, S. Chericoni, C. Martinelli, L. Testai, A. Nardi, I. Morelli, M.C. Breschi, and E. Martinotti Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels Naunyn Schmiedeberg's Arch. Pharmacol. 370 2004 290 298
95. S. Saponara, L. Testai, D. Iozzi, E. Martinotti, A. Martelli, S. Chericoni, G. Sgaragli, F. Fusi, and V. Calderone (+/-)-Naringenin as large conductance Ca(2 +)-activated K + (BKCa) channel opener in vascular smooth muscle cells Br. J. Pharmacol. 149 8 2006 1013 1021
96. W. Malakul, K. Ingkaninan, P. Sawasdee, and O.L. Woodman The ethanolic extract of Kaempferia parviflora reduces ischaemic injury in rat isolated hearts J. Ethnopharmacol. 137 2011 184 191
97. L. Testai, S. Rapposelli, A. Martelli, M.C. Breschi, and V. Calderone Mitochondrial potassium channels as pharmacological target for cardioprotective drugs Med. Res. Rev. 2014 10.1002/med.21332
98. L. Testai, A. Martelli, M. Cristofaro, M.C. Breschi, and V. Calderone Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts J. Pharm. Pharmacol. 65 2013 750 756
99. L. Testai, A. Martelli, A. Marino, V. D'Antongiovanni, F. Ciregia, L. Giusti, A. Lucacchini, S. Chericoni, M.C. Breschi, and V. Calderone The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury Biochem. Pharmacol. 85 2013 1634 1643
100. B. Yang, Q. Gao, H. Yao, and Q. Xia Mitochondrial mechanism of cardioprotective effect of puerarin against H2O2-stress in rats Zhongguo Ying Yong Sheng Li Xue Za Zhi 24 2008 399 404
101. H. Yao, Q. Gao, and Q. Xia The role of mitochondrial K + channels in the cardioprotection of puerarin against hypoxia/reoxygenation injury in rats Zhongguo Ying Yong Sheng Li Xue Za Zhi 26 2010 459 462
102. D.K. Song, Y. Jang, J.H. Kim, K.J. Chun, D. Lee, and Z. Xu Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts J. Korean Med. Sci. 25 2010 380 386
103. W.T. Chang, J. Li, M.S. Vanden Hoek, X. Zhu, C.Q. Li, H.H. Huang, C.W. Hsu, Q. Zhong, J. Li, S.J. Chen, T.L. Vanden Hoek, and Z.H. Shao Baicalein preconditioning protects cardiomyocytes from ischemia-reperfusion injury via mitochondrial oxidant signaling Am. J. Chin. Med. 41 2 2013 315 331
104. G.D. Mironova, M.I. Shigaeva, N.V. Belosludtseva, E.N. Gritsenko, K.N. Belosludtsev, E.L. Germanova, and L.D. Lukyanova Effect of several flavonoid-containing plant preparations on activity of mitochondrial ATP-dependent potassium channel Bull. Exp. Biol. Med. 146 2008 229 233
105. M. Montero, C.D. Lobaton, E. Hermandez-Sanmiguel, J. Santodomingo, L. Vay, A. Moreno, and J. Alvarez Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids Biochem. J. 384 2004 19 24
106. K. Skemiene, G. Rakauskaite, S. Trumbeckaite, J. Liobikas, G.C. Brown, and V. Borutaite Anthocyanins block ischemia-induced apoptosis in the perfused heart and support mitochondrial respiration potentially by reducing cytosolic cytochrome c Int. J. Biochem. Cell Biol. 45 2013 23 29
107. K. Škėmienė, G. Jablonskienė, J. Liobikas, and V. Borutaitė Protecting the heart against ischemia/reperfusion-induced necrosis and apoptosis: the effect of anthocyanins Medicina (Kaunas) 49 2013 84 88
108. K. Skemiene, J. Liobikas, and V. Borutaite Anthocyanins as substrates for mitochondrial complex I - protective effect against heart ischemic injury FEBS J. 2015 in press
109. D.J. Dorta, A.A. Pigoso, F.E. Mingatto, T. Rodrigues, I.M. Prado, A.F. Helena, S.A. Uyemura, A.C. Santos, and C. Curti The interaction of flavonoid with mitochondria: effects on energetic processes Chem. Biol. Interact. 152 2005 67 78
110. J. Zhang, C.P. Baines, C. Zong, E.M. Cardwell, G. Wang, T.M. Vondriska, and P. Ping Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection Am. J. Physiol. Heart Circ. Physiol. 288 2004 954 961
111. X. Liu, J. Gu, Y. Fan, H. Shi, and M. Jiang Baicalin attenuates acute myocardial infarction of rats via mediating the mitogen-activated protein kinase pathway Biol. Pharm. Bull. 36 2013 988 994
112. C. Li, J. He, Y. Gao, Y. Xing, J. Hou, and J. Tian Preventive effect of total flavones of Choerospondias axillaries on ischemia-reperfusion-induced myocardial infarction-related MAPK signaling pathway Cardiovasc. Toxicol. 14 2014 145 152
113. E.S. Park, J.C. Kang, Y.C. Jang, J.S. Park, S.Y. Jang, D.E. Kim, B. Kim, and H.S. Shin Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under HO-induced apoptosis J. Ethnopharmacol. 153 3 2014 552 560
114. N.R. Lim, C.J. Thomas, L.S. Silva, Y.Y. Yeap, S. Yap, J.R. Bell, L.M. Delbridge, M.A. Bogoyevitch, O.L. Woodman, S.J. Williams, C.N. May, and D.C. Ng Cardioprotective 3′,4′-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition Biochem. J. 456 2013 149 161
115. N. Lu, Y. Sun, and X. Zheng Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition Planta Med. 77 2011 984 991
116. H.H. Huang, Z.H. Shao, C.Q. Li, T.L. Vanden Hoek, and J. Li Baicalein protects cardiomyocytes against mitochondrial oxidant injury associated with JNK inhibition and mitochondrial Akt activation Am. J. Chin. Med. 42 2014 79 94
117. X. Zhang, P. Zhu, X. Zhang, Y. Ma, W. Li, J.M. Chen, H.M. Guo, R. Bucala, J. Zhuang, and J. Li Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway Mediat. Inflamm. 2013 2013 390890
118. M. Bartekova, S. Carnicka, D. Pancza, M. Ondrejcakova, A. Breier, and T. Ravingerova Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia Can. J. Physiol. Pharmacol. 88 2010 465 471
119. A. Annapurna, C.S. Reddy, R.B. Akondi, and S.R. Rao Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats J. Pharm. Pharmacol. 61 2009 1365 1374
120. H.B. Jin, Y.B. Yang, Y.C. Zhang, and Y.R. Li Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats Mol. Biol. Rep. 39 2012 11005 11009
121. Y. Wang, Z.Z. Zhang, Y. Wu, J.J. Ke, X.H. He, and Y.L. Wang Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway Braz. J. Med. Biol. Res. 46 2013 861 867
122. P.S. Brookes, S.B. Digerness, D.A. Parks, and V. Darley-Usman Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin Free Radic. Biol. Med. 332 2002 1220 1228
123. P.H. Liao, L.M. Hung, Y.H. Chen, Y.H. Kuan, F.B. Zhang, R.H. Lin, H.C. Shih, S.K. Tsai, and S.S. Huang Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats Circ. J. 75 2011 443 450
124. L. Qi, H. Pan, D. Li, F. Fang, D. Chen, and H. Sun Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes Eur. J. Pharmacol. 668 2011 201 207
125. F. Fang, D. Li, H. Pan, D. Chen, L. Qi, R. Zhang, and H. Sun Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through them PI3K/Akt pathway in simulated ischemia/reperfusion Pharmacology 88 2011 149 158
126. T. Xu, D. Li, and D. Jiang Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion Nutrients 4 2012 2008 2019
127. M. Madhesh, and M. Vaiyapuri Luteolin promotes mitochondrial protection during acute and chronic periods of isoproterenol induced myocardial infarction in rats Egypt Heart J. 65 2013 319 327
128. M. Hirai, Y. Hotta, N. Ishikawa, Y. Wakida, Y. Fukuzawa, F. Isobe, A. Nakano, T. Chiba, and N. Kawamura Protective effects of EGCg or GCg, a green catechin epimer, against postischemic myocardium dysfunction in guinea-pig hearts Life Sci. 80 2007 1020 1032
129. H. Ma, X. Huang, Q. Li, Y. Guan, F. Yuan, and Y. Zhang ATP-dependent potassium channels and mitochondrial permeability transition pores play roles in the cardioprotection of theaflavin in young rat J. Physiol. Sci. 61 2011 337 342
130. E. Darra, K. Shoji, S. Mariotto, and H. Suzuki Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid Genes Nutr. 2 2007 307 310
131. D.J. Hausenloy, and D.M. Yellon Reperfusion injury salvage kinase signaling: taking a RISK for cardioprotection Heart Fail. Rev. 12 2007 217 234
132. K.G. Yamazaki, D. Romero-Perez, M. Barraza-Hidalgo, M. Cruz, M. Rivas, B. Cortez-Gomez, G. Ceballos, and F. Villarreal Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 295 2 2008 H761 H767
133. K. Yamazaki, P. Raub, M. Barraza-Hidalgo, M.M. Rivas, A.C. Zambon, G. Ceballos, and F.J. Villarreal Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion J. Am. Coll. Cardiol. 55 2010 2869 2876
134. M. Panneerselvam, Y.M. Tsutsumi, J.A. Bonds, Y.T. Horikawa, M. Saldana, N.D. Dalton, B.P. Head, P.M. Patel, D.M. Roth, and H.H. Patel Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta Gao-opioid receptor stimulation Am. J. Physiol. Heart Circ. Physiol. 299 2010 H1604 H1609
135. Q. Gao, H.Y. Pan, S. Qiu, Y. Lu, I.C. Bruce, J.H. Luo, and Q. Xia Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart Life Sci. 79 2006 217 224
136. J. Chen, R. Guo, H. Yan, L. Tian, Q. You, S. Li, R. Huang, and K. Wu Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells Basic Clin. Pharmacol. Toxicol. 114 2014 293 304
137. M. Toufektsian, M. de Lorgeril, N. Nagy, P. Salen, M.B. Donati, L. Giordano, H.P. Mock, S. Peterek, A. Matros, K. Petroni, R. Pilu, D. Rotilio, C. Tonelli, J. de Leiris, F. Boucher, and C. Martin Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury J. Nutr. 138 2008 747 752
138. C.M. Porteous, A. Logan, C. Evans, E.C. Ledgerwood, D.K. Menon, F. Aigbirhio, R.A. Smith, and M.P. Murphy Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes Biochim. Biophys. Acta 1800 2010 1009 1017
139. N. Sassi, L. Biasutto, A. Mattarei, M. Carraro, V. Giorgio, A. Citta, P. Bernardi, S. Garbisa, I. Szabò, C. Paradisi, and M. Zoratti Cytotoxicity of a mitochondriotropic quercetin derivative: mechanisms Biochim. Biophys. Acta 2012 1817 1095 1106
140. A. Ghosh, S. Sarkar, A.K. Mandai, and N. Das Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats PLoS One 8 2013 e57735